pifithrin has been researched along with Lung Diseases in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Lung Diseases: Pathological processes involving any part of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HR | 1 |
| Shin, DY | 1 |
| Park, YJ | 1 |
| Park, CW | 1 |
| Oh, SM | 1 |
| Chung, KH | 1 |
1 other study available for pifithrin and Lung Diseases
| Article | Year |
|---|---|
Silver nanoparticles induce p53-mediated apoptosis in human bronchial epithelial (BEAS-2B) cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Bronchi; Caspase 3; Cells, Cultured; DNA Frag | 2014 |